4/A//SEC Filing
Chang David D 4/A
Accession 0001214659-21-003892
CIK 0001737287other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:11 PM ET
Size
8.7 KB
Accession
0001214659-21-003892
Insider Transaction Report
Form 4/AAmended
Chang David D
DirectorPresident and CEO
Transactions
- Gift
Common Stock
2020-08-31+205,778→ 856,044 total(indirect: See footnote) - Gift
Common Stock
2020-08-31+205,778→ 856,044 total(indirect: See footnote)
Holdings
- 1,201,108(indirect: See footnote)
Common Stock
- 2,284,869
Common Stock
Footnotes (5)
- [F1]Securities held in the name of the Chang 2006 Family Trust.
- [F2]On August 31, 2020, Julia Chang transferred 205,778 shares of the Issuer's common stock to the JEC 2019 Trust dated October 1, 2019, of which the Reporting Person and Jane Chang are Trustees and the Reporting Person's daughter is the beneficiary.
- [F3]Securities held in the name of the JEC 2019 Trust dated October 1, 2019.
- [F4]On August 31, 2020, Robert Chang transferred 205,778 shares of the Issuer's common stock to the RTC 2019 Trust dated October 1, 2019, of which the Reporting Person and Jane Chang are Trustees and the Reporting Person's son is the beneficiary.
- [F5]Securities held in the name of the RTC 2019 Trust dated October 1, 2019.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001611024
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 4:11 PM ET
- Size
- 8.7 KB